Allergan PLC (AGN)

AGN (NYSE:Drugs) EQUITY
$236.21
neg -7.10
-2.90%
Today's Range: 232.05 - 244.27 | AGN Avg Daily Volume: 3,129,000
Last Update: 08/25/16 - 3:59 PM EDT
Volume: 5,960,588
YTD Performance: -22.15%
Open: $243.00
Previous Close: $243.27
52 Week Range: $195.50 - $322.68
Oustanding Shares: 395,952,199
Market Cap: 100,259,056,309
6-Month Chart
TheStreet Ratings Grade for AGN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 9 9 9
Moderate Buy 3 2 3 3
Hold 3 4 4 4
Moderate Sell 0 0 1 1
Strong Sell 0 0 0 0
Mean Rec. 1.57 1.63 1.79 1.79
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 20.47
Price Earnings Comparisons:
AGN Sector Avg. S&P 500
20.47 23.50 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
6.28% -16.64% 81.69%
GROWTH 12 Mo 3 Yr CAGR
Revenue 15.40 1.60 0.36
Net Income 0.00 -30.20 0.00
EPS 0.00 12.00 1.33
Earnings for AGN:
EBITDA 5.36B
Revenue 15.07B
Average Earnings Estimates
Qtr (09/16) Qtr (12/16) FY (12/16) FY (12/17)
Average Estimate $3.64 $4.12 $13.98 $16.90
Number of Analysts 7 6 9 10
High Estimate $4.00 $4.33 $14.09 $17.47
Low Estimate $3.44 $3.99 $13.78 $16.07
Prior Year $3.48 $3.41 $13.43 $13.98
Growth Rate (Year over Year) 4.47% 20.82% 4.09% 20.89%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
The U.S. dollar is stronger. The price of crude oil fell by $1.33 to $46.77. Gold slipped by $17 to $1,329 and appears likely to threaten support at $1,300 to $1,310. Agricultural commodities. wheat -2, corn -1.5, soybean -9, oats flat. Lumber -7 on weak housing data. Bonds are down small. The 10- and 30-year note and bond yields are unchanged. So was the 2s/10s spread (80 basis points). Municipals and junk flat lined, as did Blackstone/GSO Strategic Credit Fund (BGB) and closed-end muni bond funds. Banks remain the world's fair.: Brokerages are holding in well. Same goes for insurance, but my long Hartford Financial Services Group (HIG) is a laggard. Biotech down by about 2%. Allergan (AGN) and Celgene (CELG) are leaders to the downside, with speculative biotech taken to the woodshed, too. Profit-taking continues in retail. Autos are mixed. Energy stocks nonplussed by oil's descent, thus far. Old tech is mixed, but IBM (IBM) is a downside feature. Media is down small. Ag equipment is weaker (I dissed CAT this morning, added to my short) Staples are lower on a stronger currency. In individual stocks, my longs Radian Group (RDN) and DuPont (DD) are doing God's work! Oaktree Capital Group (OAK) is trading better, but it is an odd stock and it's mostly difficult to understand its daily moves. (T)FANG all lower, but not materially. Here are some valuable contributions on our site today: Jim "El Capitan" Cramer on oil and the little guy.  Tim "Not Judy or Phil" Collins sees Babe Ruth -- i.e., Facebook (FB) -- striking out.  Skip Raschke on frowning (and shorting). Rev Shark is waiting for Godot.  Roger Arnold on a rate rise by the Fed (Fischer-style). 

Bret Jensen Reporting for Duty Real Money Pro($)

Good morning, Bret Jensen here! It's good to be standing in for Doug Kass again on the daily diary as we begin a new trading week.
Bullish
Aug 19, 2016 | 6:53 AM EDT
AGN was upgraded from Neutral to Buy, Mizuho said. $318 price target. Consensus estimates appear more reasonable and the company can de...
These managers have great track records and I have made money stealing their ideas.
Appaloosa adds to its stake in the biopharmaceutical company while Jana Partners exits its position.
Besides Tesla, Twitter and Biogen make good candidates.
The deal builds on leadership positions in Allergan's core therapeutic areas.
AAP portfolio managers Cramer and Mohr defend the drug company after it tops analysts' bottom-line expectations while missing top-line estimates.

Today's Good, Bad and Ugly Real Money Pro($)

The markets remain remarkably resilient. That said, I raised my short exposure in a small way when the market moved back to unchanged this morning. Radian Group (RDN) , placed on the Best Ideas List at $10 a share on July 6, trades at $13 today. I recently added close to $12, but I wouldn't chase at these levels even though I have an upside price target in the high teens.  Selected retail stocks are up on the heels of today's takeover of a mattress company. I am being squeezed a bit in my Nordstrom (JWN) short, but it's come down a long way. Agricultural equipment stocks are higher on a continued rise in ag commodities. I am poised to re-short the Caterpillar (CAT) I covered (it was on the Best Ideas List for several years). Banks are holding firm after a strong run on Friday. I am still re-examining a Financial Select Sector SPDR ETF (XLF) short as I think the pathway to higher yields and lower bond prices will be slow but steady. The Bad (T)FANG is rolling over a bit, but nothing monumental. Speculative biotech. (An editorial statement: I see a lot of shots being taken in our Comments Section on small-cap biotech and others. It's not my game and subs should be mindful of risks and size accordingly. I also think "shot taking' is symptomatic of the attitude we get when the market is frothy and overextended. I write this respectfully and out of concern.) I continue to add to Hartford Financial Services Group (

Columnist Conversations

We have followed all areas of the Healthcare industry for decades. And while there are likely many causes for ...
Shares of Dollar General (DG) got hammered today after fiscal Q2 EPS came in at $1.08 versus a $1.09 estimate....
Before the open today, I noted to our members that crude oil is starting to look and act like the correction o...
Stocks continue to meander in very narrow ranges as investors appear hesitant to make any moves in front of to...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.